These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 27418009)

  • 1. The Blood and Marrow Transplant Clinical Trials Network: An Effective Infrastructure for Addressing Important Issues in Hematopoietic Cell Transplantation.
    Steering Committee Of The Blood And Marrow Transplant Clinical Trials Network
    Biol Blood Marrow Transplant; 2016 Oct; 22(10):1747-1757. PubMed ID: 27418009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood and marrow transplant clinical trials network (BMT CTN): addressing unanswered questions.
    Weisdorf D; Carter S; Confer D; Ferrara J; Horowitz M
    Biol Blood Marrow Transplant; 2007 Mar; 13(3):257-62; discussion 255-6. PubMed ID: 17317578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bringing Patient and Caregivers Voices to the Clinical Trial Chorus: A Report From the BMT CTN Patient and Caregiver Advocacy Task Force.
    Vasu S; Holtan SG; Shimamura A; Burnworth T; Whisenton S; Adams S; Nuechterlein B; Mortier N; Foster J; DiFronzo N; Horowitz M; Rizzo D; Foley A
    Transplant Cell Ther; 2023 Jan; 29(1):5-9. PubMed ID: 36283516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonmyeloablative stem cell transplantation for the treatment of cancer and life-threatening nonmalignant disorders: past accomplishments and future goals.
    Slavin S; Or R; Aker M; Shapira MY; Panigrahi S; Symeonidis A; Cividalli G; Nagler A
    Cancer Chemother Pharmacol; 2001 Aug; 48 Suppl 1():S79-84. PubMed ID: 11587373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma.
    Giralt S; Garderet L; Durie B; Cook G; Gahrton G; Bruno B; Hari P; Lokhorst H; McCarthy P; Krishnan A; Sonneveld P; Goldschmidt H; Jagannath S; Barlogie B; Mateos M; Gimsing P; Sezer O; Mikhael J; Lu J; Dimopoulos M; Mazumder A; Palumbo A; Abonour R; Anderson K; Attal M; Blade J; Bird J; Cavo M; Comenzo R; de la Rubia J; Einsele H; Garcia-Sanz R; Hillengass J; Holstein S; Johnsen HE; Joshua D; Koehne G; Kumar S; Kyle R; Leleu X; Lonial S; Ludwig H; Nahi H; Nooka A; Orlowski R; Rajkumar V; Reiman A; Richardson P; Riva E; San Miguel J; Turreson I; Usmani S; Vesole D; Bensinger W; Qazilbash M; Efebera Y; Mohty M; Gasparreto C; Gajewski J; LeMaistre CF; Bredeson C; Moreau P; Pasquini M; Kroeger N; Stadtmauer E
    Biol Blood Marrow Transplant; 2015 Dec; 21(12):2039-2051. PubMed ID: 26428082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translation of Clinical Research into Practice: An Impact Assessment of the Results from the Blood and Marrow Transplant Clinical Trials Network Protocol 0201 on Unrelated Graft Source Utilization.
    Khera N; Mau LW; Denzen EM; Meyer C; Houg K; Lee SJ; Horowitz MM; Burns LJ
    Biol Blood Marrow Transplant; 2018 Nov; 24(11):2204-2210. PubMed ID: 29966761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recommendations for donor human leukocyte antigen assessment and matching for allogeneic stem cell transplantation: consensus opinion of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN).
    Howard CA; Fernandez-Vina MA; Appelbaum FR; Confer DL; Devine SM; Horowitz MM; Mendizabal A; Laport GG; Pasquini MC; Spellman SR
    Biol Blood Marrow Transplant; 2015 Jan; 21(1):4-7. PubMed ID: 25278457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining and Grading Infections in Clinical Trials Involving Hematopoietic Cell Transplantation: A Report From the BMT CTN Infectious Disease Technical Committee.
    Shahid Z; Etra AM; Levine JE; Riches ML; Baluch A; Hill JA; Nakamura R; Toor AA; Ustun C; Young JH; Perales MA; Epstein DJ; Murthy HS
    Transplant Cell Ther; 2024 May; 30(5):540.e1-540.e13. PubMed ID: 38458478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood and Marrow Transplant Clinical Trials Network: progress since the State of the Science Symposium 2007.
    Ferrara JL
    Biol Blood Marrow Transplant; 2014 Feb; 20(2):149-53. PubMed ID: 24239651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults.
    Holtick U; Albrecht M; Chemnitz JM; Theurich S; Skoetz N; Scheid C; von Bergwelt-Baildon M
    Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD010189. PubMed ID: 24748537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-reported physical functioning predicts the success of hematopoietic cell transplantation (BMT CTN 0902).
    Wood WA; Le-Rademacher J; Syrjala KL; Jim H; Jacobsen PB; Knight JM; Abidi MH; Wingard JR; Majhail NS; Geller NL; Rizzo JD; Fei M; Wu J; Horowitz MM; Lee SJ
    Cancer; 2016 Jan; 122(1):91-8. PubMed ID: 26439325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematopoietic Cell Transplantation: Practice Predictions for the Year 2023.
    Farhadfar N; Burns LJ; Mupfudze T; Shaw BE; Bollard CM; Devine SM; Horowitz MM; Jones RJ; Murthy HS; Wingard JR; Lee SJ
    Transplant Cell Ther; 2021 Feb; 27(2):183.e1-183.e7. PubMed ID: 33045387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From evidence to clinical practice in blood and marrow transplantation.
    Khera N
    Blood Rev; 2015 Nov; 29(6):351-7. PubMed ID: 25934009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Center Experience with Donor Type on Outcomes: A Secondary Analysis, Blood and Marrow Transplant Clinical Trials Network 1101Open for Accrual June 2012Open for Accrual June 2012.
    Brunstein CG; O'Donnell PV; Logan B; Dawson P; Costa L; Cutler C; Craig M; Hogan W; Horowitz MM; Horwitz ME; Karanes C; Magenau JM; Malone A; McCarty J; McGuirk JP; Morris LE; Rezvani AR; Salit R; Vasu S; Eapen M; Fuchs EJ;
    Transplant Cell Ther; 2022 Jul; 28(7):406.e1-406.e6. PubMed ID: 35390529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretransplantation Exercise and Hematopoietic Cell Transplantation Survival: A Secondary Analysis of Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0902).
    Wingard JR; Wood WA; Martens M; Le-Rademacher J; Logan B; Knight JM; Jacobsen PB; Jim H; Majhail NS; Syrjala K; Rizzo JD; Lee SJ
    Biol Blood Marrow Transplant; 2017 Jan; 23(1):161-164. PubMed ID: 27742574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow transplantation in the United Kingdom - past, present and future.
    Barrett J; Craddock C
    Br J Haematol; 2020 Nov; 191(4):612-616. PubMed ID: 33190255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of registries in facilitating clinical research in BMT: examples from the Center for International Blood and Marrow Transplant Research.
    Horowitz M
    Bone Marrow Transplant; 2008 Aug; 42 Suppl 1():S1-S2. PubMed ID: 18724277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Male-Specific Late Effects in Adult Hematopoietic Cell Transplantation Recipients: A Systematic Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation.
    Phelan R; Im A; Hunter RL; Inamoto Y; Lupo-Stanghellini MT; Rovo A; Badawy SM; Burns L; Eissa H; Murthy HS; Prasad P; Sharma A; Suelzer E; Agrawal V; Aljurf M; Baker K; Basak GW; Buchbinder D; DeFilipp Z; Grkovic LD; Dias A; Einsele H; Eisenberg ML; Epperla N; Farhadfar N; Flatau A; Gale RP; Greinix H; Hamilton BK; Hashmi S; Hematti P; Jamani K; Maharaj D; Murray J; Naik S; Nathan S; Pavletic S; Peric Z; Pulanic D; Ross R; Salonia A; Sanchez-Ortega I; Savani BN; Schechter T; Shah AJ; Smith SM; Snowden JA; Steinberg A; Tremblay D; Vij SC; Walker L; Wolff D; Yared JA; Schoemans H; Tichelli A
    Transplant Cell Ther; 2022 Jun; 28(6):335.e1-335.e17. PubMed ID: 34757220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Sirolimus on Immune Reconstitution Following Myeloablative Allogeneic Stem Cell Transplantation: An Ancillary Analysis of a Randomized Controlled Trial Comparing Tacrolimus/Sirolimus and Tacrolimus/Methotrexate (Blood and Marrow Transplant Clinical Trials Network/BMT CTN 0402).
    Gooptu M; Kim HT; Howard A; Choi SW; Soiffer RJ; Antin JH; Ritz J; Cutler CS
    Biol Blood Marrow Transplant; 2019 Nov; 25(11):2143-2151. PubMed ID: 31271885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Cell Transplantation for Inherited Bone Marrow Failure Syndromes: Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation.
    Dietz AC; Mehta PA; Vlachos A; Savage SA; Bresters D; Tolar J; Boulad F; Dalle JH; Bonfim C; de la Fuente J; Duncan CN; Baker KS; Pulsipher MA; Lipton JM; Wagner JE; Alter BP
    Biol Blood Marrow Transplant; 2017 May; 23(5):726-735. PubMed ID: 28115275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.